How to get Ozempic in 2026: the honest pathway

“How do I get Ozempic?” has a different answer depending on a single question: why do you want it? Ozempic is a diabetes drug, and that one fact drives everything — who can prescribe it, whether insurance pays, and whether you should actually be asking about a different drug entirely. Here’s the honest pathway.

First, the thing most guides skip: Ozempic is a diabetes drug

Ozempic (semaglutide) is FDA-approved to improve blood sugar in adults with type-2 diabetes, to reduce cardiovascular events in diabetics with heart disease, and (since 2025) to slow kidney-disease progression in diabetics with chronic kidney disease.^[1] It is not FDA-approved for weight loss. The semaglutide drug that is approved for weight loss is Wegovy — same molecule, different brand and indication. So the first fork in the road is your reason for wanting it.

If you have type-2 diabetes (the on-label route)

This is the straightforward path. A primary-care doctor or endocrinologist diagnoses type-2 diabetes (typically via A1c or fasting glucose) and can prescribe Ozempic on-label. Because it’s being used for its approved purpose, commercial plans and Medicare Part D commonly cover it — subject to formulary tier, prior authorization, and sometimes step therapy (trying a cheaper drug like metformin first).^[2] If your plan covers it, Novo’s savings card can bring the copay to as little as $25/month (capped at $100/month savings, for up to 48 months) — for commercially insured patients only.^[2]

If you want it for weight loss (the off-label reality)

A doctor may legally prescribe Ozempic off-label for weight loss at their discretion, and some in-person and telehealth clinicians do. But two things make this the harder road: insurance generally will not cover Ozempic for weight loss, and the manufacturer savings card is tied to the approved diabetes indication, so it won’t rescue an off-label prescription.^[2]That’s exactly why the sensible move for most people without diabetes is the on-label sibling: Wegovy (or, for tirzepatide, Zepbound). See our Ozempic vs Wegovy comparison for why they’re the same drug pointed at different goals.

What it costs, and the cash options

Ozempic’s list price is about $936 a month — a number Novo has said will fall to $675 on January 1, 2027.^[2] Almost no one with a working route pays the sticker, though. For uninsured patients, Novo’s self-pay offer runs about $199/month for the first two months (lower-dose pens), then roughly $349–$499 depending on the pen strength.^[2] The full breakdown lives in our semaglutide cost guide and GLP-1 cost and insurance explainer, and you can model your own scenario in the GLP-1 cost estimator.

What about compounded Ozempic?

During the 2023–24 shortage, cheap compounded semaglutide was everywhere. That door has largely closed. Semaglutide came off the FDA shortage list in early 2025, ending the mass compounding exemption, and in 2026 the FDA moved to permanently bar semaglutide from large-scale compounding.^[3] Narrow, patient-specific compounding can still be legal with a documented medical need, but a cheap “compounded Ozempic” subscription is no longer a reliable or clearly-legal route — read our compounded vs branded guide before going that way.

The honest bottom line

If you have type-2 diabetes, getting Ozempic is straightforward and often covered — see a doctor, confirm the diagnosis, and use the savings card if you’re commercially insured.^[2] If you want it purely for weight loss, Ozempic is off-label and usually uncovered, and the right question is really about Wegovy (or Zepbound). Whichever applies, compare the legitimate telehealth routes in our best GLP-1 providers roundup, and start from the evidence in our semaglutide evidence guide.